- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Somatostatin market will register a 11.8% CAGR in terms of revenue, the global market size will reach $ 411.5 million by 2025, from $ 263.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Somatostatin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Somatostatin market by type, application, key manufacturers and key regions and countries.
This study considers the Somatostatin value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
0.25
0.75
3
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hormonal Disorder
Oncology
Metabolic Disorder
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck (Schweiz) AG
Yangtze River
SANOFI-AVENTIS FRANCE
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
Lyomark Pharma GmbH
HYBIO
SAMARTH
TianTaiShan
UBPL
Qingdao Guoda
Longjin
Chengdu Shengnuo
Siyao
SL PHARM
Hainan Zhonghe
Wuhan Hualong
Shuangcheng
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Somatostatin consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Somatostatin market by identifying its various subsegments.
Focuses on the key global Somatostatin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Somatostatin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Somatostatin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Somatostatin Consumption 2015-2025
2.1.2 Somatostatin Consumption CAGR by Region
2.2 Somatostatin Segment by Type
2.2.1 0.25
2.2.2 0.75
2.2.3 3
2.3 Somatostatin Consumption by Type
2.3.1 Global Somatostatin Consumption Market Share by Type (2015-2020)
2.3.2 Global Somatostatin Revenue and Market Share by Type (2015-2020)
2.3.3 Global Somatostatin Sale Price by Type (2015-2020)
2.4 Somatostatin Segment by Application
2.4.1 Hormonal Disorder
2.4.2 Oncology
2.4.3 Metabolic Disorder
2.4.4 Others
2.5 Somatostatin Consumption by Application
2.5.1 Global Somatostatin Consumption Market Share by Type (2015-2020)
2.5.2 Global Somatostatin Value and Market Share by Type (2015-2020)
2.5.3 Global Somatostatin Sale Price by Type (2015-2020)
3 Global Somatostatin by Company
3.1 Global Somatostatin Sales Market Share by Company
3.1.1 Global Somatostatin Sales by Company (2018-2020)
3.1.2 Global Somatostatin Sales Market Share by Company (2018-2020)
3.2 Global Somatostatin Revenue Market Share by Company
3.2.1 Global Somatostatin Revenue by Company (2018-2020)
3.2.2 Global Somatostatin Revenue Market Share by Company (2018-2020)
3.3 Global Somatostatin Sale Price by Company
3.4 Global Somatostatin Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Somatostatin Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Somatostatin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Somatostatin by Regions
4.1 Somatostatin by Regions
4.2 Americas Somatostatin Consumption Growth
4.3 APAC Somatostatin Consumption Growth
4.4 Europe Somatostatin Consumption Growth
4.5 Middle East & Africa Somatostatin Consumption Growth
5 Americas
5.1 Americas Somatostatin Consumption by Countries
5.1.1 Americas Somatostatin Consumption by Countries (2015-2020)
5.1.2 Americas Somatostatin Value by Countries (2015-2020)
5.2 Americas Somatostatin Consumption by Type
5.3 Americas Somatostatin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Somatostatin Consumption by Regions
6.1.1 APAC Somatostatin Consumption by Regions (2015-2020)
6.1.2 APAC Somatostatin Value by Regions (2015-2020)
6.2 APAC Somatostatin Consumption by Type
6.3 APAC Somatostatin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Somatostatin by Countries
7.1.1 Europe Somatostatin Consumption by Countries (2015-2020)
7.1.2 Europe Somatostatin Value by Countries (2015-2020)
7.2 Europe Somatostatin Consumption by Type
7.3 Europe Somatostatin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Somatostatin by Countries
8.1.1 Middle East & Africa Somatostatin Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Somatostatin Value by Countries (2015-2020)
8.2 Middle East & Africa Somatostatin Consumption by Type
8.3 Middle East & Africa Somatostatin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Somatostatin Distributors
10.3 Somatostatin Customer
11 Global Somatostatin Market Forecast
11.1 Global Somatostatin Consumption Forecast (2021-2025)
11.2 Global Somatostatin Forecast by Regions
11.2.1 Global Somatostatin Forecast by Regions (2021-2025)
11.2.2 Global Somatostatin Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Somatostatin Forecast by Type
11.8 Global Somatostatin Forecast by Application
12 Key Players Analysis
12.1 Merck (Schweiz) AG
12.1.1 Company Information
12.1.2 Somatostatin Product Offered
12.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Merck (Schweiz) AG Latest Developments
12.2 Yangtze River
12.2.1 Company Information
12.2.2 Somatostatin Product Offered
12.2.3 Yangtze River Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Yangtze River Latest Developments
12.3 SANOFI-AVENTIS FRANCE
12.3.1 Company Information
12.3.2 Somatostatin Product Offered
12.3.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 SANOFI-AVENTIS FRANCE Latest Developments
12.4 ALFA WASSERMANN S.p.A.
12.4.1 Company Information
12.4.2 Somatostatin Product Offered
12.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 ALFA WASSERMANN S.p.A. Latest Developments
12.5 Polypeptide Laboratories, Inc
12.5.1 Company Information
12.5.2 Somatostatin Product Offered
12.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Polypeptide Laboratories, Inc Latest Developments
12.6 Lyomark Pharma GmbH
12.6.1 Company Information
12.6.2 Somatostatin Product Offered
12.6.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Lyomark Pharma GmbH Latest Developments
12.7 HYBIO
12.7.1 Company Information
12.7.2 Somatostatin Product Offered
12.7.3 HYBIO Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 HYBIO Latest Developments
12.8 SAMARTH
12.8.1 Company Information
12.8.2 Somatostatin Product Offered
12.8.3 SAMARTH Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 SAMARTH Latest Developments
12.9 TianTaiShan
12.9.1 Company Information
12.9.2 Somatostatin Product Offered
12.9.3 TianTaiShan Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 TianTaiShan Latest Developments
12.10 UBPL
12.10.1 Company Information
12.10.2 Somatostatin Product Offered
12.10.3 UBPL Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 UBPL Latest Developments
12.11 Qingdao Guoda
12.11.1 Company Information
12.11.2 Somatostatin Product Offered
12.11.3 Qingdao Guoda Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Qingdao Guoda Latest Developments
12.12 Longjin
12.12.1 Company Information
12.12.2 Somatostatin Product Offered
12.12.3 Longjin Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Longjin Latest Developments
12.13 Chengdu Shengnuo
12.13.1 Company Information
12.13.2 Somatostatin Product Offered
12.13.3 Chengdu Shengnuo Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Chengdu Shengnuo Latest Developments
12.14 Siyao
12.14.1 Company Information
12.14.2 Somatostatin Product Offered
12.14.3 Siyao Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Siyao Latest Developments
12.15 SL PHARM
12.15.1 Company Information
12.15.2 Somatostatin Product Offered
12.15.3 SL PHARM Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 SL PHARM Latest Developments
12.16 Hainan Zhonghe
12.16.1 Company Information
12.16.2 Somatostatin Product Offered
12.16.3 Hainan Zhonghe Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Hainan Zhonghe Latest Developments
12.17 Wuhan Hualong
12.17.1 Company Information
12.17.2 Somatostatin Product Offered
12.17.3 Wuhan Hualong Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Wuhan Hualong Latest Developments
12.18 Shuangcheng
12.18.1 Company Information
12.18.2 Somatostatin Product Offered
12.18.3 Shuangcheng Somatostatin Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Shuangcheng Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Somatostatin Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 0.25
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
